Table 2.
Biophysical data of the peptide analogs
| Peptidesa | tR (min)b | Benignc | 50% TFEd | ||
|---|---|---|---|---|---|
| 25°C | [θ]222 | % helixe | [θ]222 | % helixe | |
| P | 46.9 | −14550 | 36.66 | −39700 | 100.00 |
| K7D | 44.1 | −6050 | 15.22 | −30900 | 77.77 |
| K14D | 43.5 | −15550 | 39.16 | −35250 | 88.72 |
| K22D | 43.3 | −8400 | 21.14 | −33950 | 85.48 |
| K7D/K14D | 40.9 | −8750 | 22.02 | −28450 | 71.65 |
| K14D/K22D | 40.1 | −6350 | 15.95 | −32150 | 81.00 |
| K7D/K14D/K22D | 37.9 | −5000 | 12.59 | −26350 | 66.33 |
| K7D/K10D/K14D/K22D | 35.5 | −7350 | 22.48 | −19400 | 48.84 |
| K3D/K7D/K10D/K14D/K22D | 34.6 | −4750 | 14.59 | −21400 | 53.99 |
| K1D/K3D/K7D/K10D/K14D/K22D | 34.6 | −5800 | 17.74 | −19300 | 48.61 |
| L6D | 44.6 | −8500 | 21.45 | −39550 | 99.61 |
| L12D | 42.9 | −8350 | 21.01 | −37750 | 95.08 |
| L20D | 42.5 | −6900 | 17.42 | −36900 | 92.90 |
| L6D/L12D | 40.8 | −6800 | 17.14 | −29050 | 73.13 |
| L12D/L20D | 37.8 | −5550 | 13.93 | −30050 | 75.69 |
| L6D/L12D/L20D | 37.4 | −4950 | 12.45 | −28450 | 71.66 |
| L6D/L12D /L17D/L20D | 36.3 | −4050 | 12.46 | −15050 | 37.88 |
| L6D/L12D /L17D/L20D /L21D | 34.8 | −3600 | 10.97 | −13150 | 33.20 |
aPeptides are ordered by relative hydrophobicity
btR (min) denotes the retention time at 25°C by RP-HPLC
cThe mean residue molar ellipticities, [θ]222 (degree cm2 dmol−1) at wavelength 222 nm were measured at 25°C in KP buffer (100 mmol/L KCl, 50 mmol/L PO4, pH 7.0)
dThe mean residue molar ellipticities, [θ]222 (degree cm2 dmol−1) at wavelength 222 nm were measured at 25°C in KP buffer with 50% TFE
eThe helical content (in percentage) of a peptide relative to the molar ellipticity value of peptide P in 50% TFE